Herzog · Psychoneuroendocrinology 2013 · randomized crossover trial · n=16

Selective slow wave sleep but not rapid eye movement sleep suppression impairs morning glucose tolerance in healthy men.

Cited 102 times in the scientific literature.

Level 2 - randomized trial

Individual randomized crossover trial

PubMed 23602132 · doi:10.1016/j.psyneuen.2013.03.018 · record verified 2026-08-31

What was done

Sixteen healthy men completed three experimental conditions in a crossover design: selective slow wave sleep (SWS) suppression, rapid eye movement (REM) sleep disturbance, and regular sleep. Selective sleep stage disruption was delivered using an acoustic tone (532 Hz) with gradually rising sound intensity. Morning glucoregulatory parameters were assessed via an oral glucose tolerance test (OGTT).

What was found

Selective SWS suppression significantly increased morning plasma glucose and serum insulin responses, reducing postprandial insulin sensitivity by up to 20% as measured by the Matsuda Index. Disturbed REM sleep did not affect morning glucose homeostasis. Specific baseline and post-intervention concentrations, standard deviations, and exact p-values were not provided in the abstract.

Why it matters

This study demonstrates that the acute metabolic disruption associated with poor sleep is stage-specific, implicating slow wave sleep deprivation rather than general sleep fragmentation or REM loss as the primary driver of impaired glucose tolerance.

Limits

The trial had a very small sample size (n = 16) and included only healthy men, limiting generalizability to women, older adults, or clinical populations. Only acute next-morning responses were evaluated, leaving long-term metabolic adaptations unmeasured.

Cited by